共 50 条
- [5] Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy [J]. CANCER RESEARCH AND TREATMENT, 2024, 56 (01): : 247 - 258
- [7] Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma [J]. PLOS ONE, 2019, 14 (05):
- [10] Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy [J]. Journal of Gastrointestinal Surgery, 2023, 27 : 337 - 346